- Home
- PLRX vs BRID Comparison
PLRX vs BRID Comparison
Compare PLRX & BRID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- BRID
- Stock Information
- Founded
- PLRX 2015
- BRID 1932
- Country
- PLRX United States
- BRID United States
- Employees
- PLRX N/A
- BRID N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- BRID Specialty Foods
- Sector
- PLRX Health Care
- BRID Consumer Staples
- Exchange
- PLRX Nasdaq
- BRID Nasdaq
- Market Cap
- PLRX 87.0M
- BRID 72.6M
- IPO Year
- PLRX 2020
- BRID N/A
- Fundamental
- Price
- PLRX $1.46
- BRID $7.85
- Analyst Decision
- PLRX Hold
- BRID
- Analyst Count
- PLRX 10
- BRID 0
- Target Price
- PLRX $9.79
- BRID N/A
- AVG Volume (30 Days)
- PLRX 1.4M
- BRID 5.4K
- Earning Date
- PLRX 05-05-2025
- BRID 05-30-2025
- Dividend Yield
- PLRX N/A
- BRID N/A
- EPS Growth
- PLRX N/A
- BRID N/A
- EPS
- PLRX N/A
- BRID N/A
- Revenue
- PLRX N/A
- BRID $221,348,000.00
- Revenue This Year
- PLRX N/A
- BRID N/A
- Revenue Next Year
- PLRX N/A
- BRID N/A
- P/E Ratio
- PLRX N/A
- BRID N/A
- Revenue Growth
- PLRX N/A
- BRID N/A
- 52 Week Low
- PLRX $1.10
- BRID $7.66
- 52 Week High
- PLRX $16.52
- BRID $14.69
- Technical
- Relative Strength Index (RSI)
- PLRX 37.18
- BRID 28.80
- Support Level
- PLRX $1.10
- BRID $7.66
- Resistance Level
- PLRX $1.34
- BRID $8.40
- Average True Range (ATR)
- PLRX 0.12
- BRID 0.37
- MACD
- PLRX 0.15
- BRID 0.02
- Stochastic Oscillator
- PLRX 88.45
- BRID 16.10
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.